Loading
Everything in development, the open problems and what is being done about them, the roadmaps, and what changed on this record.
What is in development for WNT-activated medulloblastoma, drawn from the whole corpus: 3 items. Drugs are grouped by the most advanced trial phase they have reached anywhere; approved treatments sit under standard of care. Technologies are the methods being tested for this cancer, trials are the studies recorded here, and ideas are proposals not yet in a trial.
How far craniospinal radiotherapy can be reduced without losing cures.
Whether adult and metastatic WNT tumours share the childhood prognosis.
Nothing recorded yet.
Nothing recorded yet.
Also on OnCo: Atlas of advanced disease · How cancer spreads: the metastasis stages.
No drug targets the mutant beta-catenin pathway.
Dated changes read from the records linked to this cancer: approvals, regulatory steps, reported trials, guideline versions and milestones. Newest first; no date is inferred.
On EdgeAll 7 changes by month →When this page itself was last checked or edited.
Involved-field boost non-inferior (5-year EFS 82.
A milestone in how this cancer is treated.
A milestone in how this cancer is treated.
A milestone in how this cancer is treated.
A milestone in how this cancer is treated.